Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2113| Title: | Blinding and bias in randomized controlled trials: when to measure the effectiveness of blinding | Authors: | Boyd, Roslyn N. Edwards, Priya Copeland, Lisa Sakzewski, Leanne Thorley, Megan Ware, Robert S. Kentish, Megan |
Issue Date: | 2020 | Publisher: | Wiley-Blackwell | Source: | Malden, Massachusetts: Wiley-Blackwell Developmental Medicine & Child Neurology 62 , 2020, p. 260-260 | Pages: | 260-260 | Journal Title: | Developmental Medicine & Child Neurology | Abstract: | This article is commented on by Day on page 159 of this issue.Accession Number: 141155616. Language: English. Entry Date: 20200425. Revision Date: 20210201. Publication Type: letter; commentary. Journal Subset: Biomedical; Editorial Board Reviewed; Europe; Expert Peer Reviewed; Peer Reviewed; UK & Ireland. NLM UID: 0006761.PMID: NLM31571206. | DOI: | 10.1111/dmcn.14369 | Resources: | https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,athens&db=ccm&AN=141155616&site=ehost-live | Keywords: | Botulinum ToxinsMovement Disorders;Cerebral Palsy;Double-Blind Studies;Child | Type: | GEN |
| Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.